← SynDRA
BI-D1870
SynDRA canonical compound SYN0048664 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | RPS6KA3 |
|---|
| Mechanism of action | Ribosomal protein inhibitor |
|---|
All known targets
- RPS6KA1
- RPS6KA2
- RPS6KA3
- RPS6KA6
Mechanisms of action (all sources)
- Ribosomal protein inhibitor
- RPS6KA1 INHIBITOR
- RPS6KA2 INHIBITOR
- RPS6KA3 INHIBITOR
- RPS6KA6 INHIBITOR
Cross-references
Synonyms
- 2-((3,5-difluoro-4-hydroxyphenyl)amino)-8-isopentyl-5,7-dimethyl-7,8-dihydropteridin-6(5H)-one
- 2-(3,5-difluoro-4-hydroxyanilino)-5,7-dimethyl-8-(3-methylbutyl)-7H-pteridin-6-one
- C19H23F2N5O2
- 2-(3,5-difluoro-4-hydroxyphenylamino)-8-isopentyl-5,7-dimethyl-7,8-dihydropteridin-6(5H)-one
- BI-D 1870
- CHEMBL573107
- GTPL8038
- SCHEMBL13881333
- CTK8I8998
- BDBM25017
- DTXSID40648506
- BID1870
- MolPort-008-266-821
- HMS3244D11
- HMS3244C12
- HMS3244C11
- BCPP000343
- HMS3651D17
- BCP01977
- EX-A2471
- NSC747342
- RefChem:917143
- MFCD11223662
- WLN44M8WHJ
- orb1301013
- SCHEMBL30013787
- HMS3674C15
- BI-D1870?
- s2843
- AKOS015918879
- CCG-268540
- CS-1243
- NSC-747342
- SB19282
- NCGC00651728-01
- AC-32826
- AS-16192
- FD102472
- HY-10510
Look up BI-D1870 in the interactive SynDRA portal →